Literature DB >> 26363782

A novel Dock8 gene mutation confers diabetogenic susceptibility in the LEW.1AR1/Ztm-iddm rat, an animal model of human type 1 diabetes.

Tanja Arndt1, Dirk Wedekind2, Anne Jörns1, Georgios Tsiavaliaris3, Edwin Cuppen4, Hans-Jürgen Hedrich5, Sigurd Lenzen6.   

Abstract

AIMS/HYPOTHESIS: The LEW.1AR1-iddm rat, an animal model of human type 1 diabetes, arose through a spontaneous mutation within the inbred strain LEW.1AR1. A susceptibility locus (Iddm8) on rat chromosome 1 (RNO1) has been identified previously, which is accompanied by autoimmune diabetes and the additional phenotype of a variable CD3(+) T cell frequency.
METHODS: In the present study we characterised the Iddm8 region on RNO1 in backcross strains using the genetically divergent Brown Norway (BN) and Paris (PAR) rats. Candidate genes of the Iddm8 region were sequenced for mutation analysis.
RESULTS: The Iddm8 region could be subdivided by single nucleotide polymorphism (SNP) analyses. In the first region, a mutation in exon 44 of the Dock8 gene was identified resulting in an amino acid exchange in the protein from glutamine to glutamate. This exchange is unique for the LEW.1AR1-iddm rat. In the second region, a SNP was detected in exon 11 of the Vwa2 gene with an exchange from arginine to tryptophan. This SNP is also present in other rat strains. CONCLUSIONS/
INTERPRETATION: The Dock8 mutation gave rise to a new type 1 diabetes rat model with very close similarity to type 1 diabetes in humans, providing a deepened insight into the impact of genes involved in diabetes development.

Entities:  

Keywords:  Animal model; Mutation; T cells; Type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26363782     DOI: 10.1007/s00125-015-3757-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

1.  Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.

Authors:  D Fang; H Y Wang; N Fang; Y Altman; C Elly; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

2.  DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1.

Authors:  Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Eiko Iwata; Jens V Stein; Takehiko Sasazuki; Yoshinori Fukui
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

3.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

Authors:  Yosuke Harada; Yoshihiko Tanaka; Masao Terasawa; Markus Pieczyk; Katsuyoshi Habiro; Tomoya Katakai; Kyoko Hanawa-Suetsugu; Mutsuko Kukimoto-Niino; Tomoko Nishizaki; Mikako Shirouzu; Xuefeng Duan; Takehito Uruno; Akihiko Nishikimi; Fumiyuki Sanematsu; Shigeyuki Yokoyama; Jens V Stein; Tatsuo Kinashi; Yoshinori Fukui
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

4.  Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.

Authors:  Anne Jörns; Klaus Jan Rath; Taivankhuu Terbish; Tanja Arndt; Andreas Meyer Zu Vilsendorf; Dirk Wedekind; Hans-Jürgen Hedrich; Sigurd Lenzen
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 5.  GEF what? Dock180 and related proteins help Rac to polarize cells in new ways.

Authors:  Jean-François Côté; Kristiina Vuori
Journal:  Trends Cell Biol       Date:  2007-08-31       Impact factor: 20.808

Review 6.  Cellular signaling for activation of Rho GTPase Cdc42.

Authors:  Soniya Sinha; Wannian Yang
Journal:  Cell Signal       Date:  2008-05-16       Impact factor: 4.315

7.  New inbred strain of Long-Evans Tokushima lean rats with IDDM without lymphopenia.

Authors:  K Kawano; T Hirashima; S Mori; Y Saitoh; M Kurosumi; T Natori
Journal:  Diabetes       Date:  1991-11       Impact factor: 9.461

8.  Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene.

Authors:  Armand J MacMurray; Daniel H Moralejo; Anne E Kwitek; Elizabeth A Rutledge; Brian Van Yserloo; Paul Gohlke; Sara J Speros; Ben Snyder; Jonathan Schaefer; Sabine Bieg; Jianjie Jiang; Ruth A Ettinger; Jessica Fuller; Terri L Daniels; Anna Pettersson; Kimberly Orlebeke; Bruce Birren; Howard J Jacob; Eric S Lander; Ake Lernmark
Journal:  Genome Res       Date:  2002-07       Impact factor: 9.043

9.  Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production.

Authors:  Katrina L Randall; Teresa Lambe; Andy L Johnson; Andy Johnson; Bebhinn Treanor; Edyta Kucharska; Heather Domaschenz; Belinda Whittle; Lina E Tze; Anselm Enders; Tanya L Crockford; Tiphaine Bouriez-Jones; Duncan Alston; Jason G Cyster; Michael J Lenardo; Fabienne Mackay; Elissa K Deenick; Stuart G Tangye; Tyani D Chan; Tahra Camidge; Robert Brink; Carola G Vinuesa; Facundo D Batista; Richard J Cornall; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

10.  A genome-wide SNP panel for mapping and association studies in the rat.

Authors:  Isaäc J Nijman; Sylvia Kuipers; Mark Verheul; Victor Guryev; Edwin Cuppen
Journal:  BMC Genomics       Date:  2008-02-25       Impact factor: 3.969

View more
  4 in total

1.  Changes in immune cell frequencies in primary and secondary lymphatic organs of LEW.1AR1-iddm rats, a model of human type 1 diabetes compared to other MHC congenic LEW inbred strains.

Authors:  Tanja Arndt; Anne Jörns; Dirk Wedekind
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 2.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

Review 3.  Experimental Diabetes Mellitus in Different Animal Models.

Authors:  Amin Al-Awar; Krisztina Kupai; Médea Veszelka; Gergő Szűcs; Zouhair Attieh; Zsolt Murlasits; Szilvia Török; Anikó Pósa; Csaba Varga
Journal:  J Diabetes Res       Date:  2016-08-09       Impact factor: 4.011

Review 4.  Drosophila melanogaster as a Model for Diabetes Type 2 Progression.

Authors:  Jéssica P Álvarez-Rendón; Rocío Salceda; Juan R Riesgo-Escovar
Journal:  Biomed Res Int       Date:  2018-04-24       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.